Replies to post #31495 on Intellipharmaceutics International Inc. (IPCI)

[wimuskyfisherman]

Tilator- Percentage on PAR deal is likely not going up. With all doses on market though, IPCI should get $4-5M in revenue on Focalin XR for FY 2018. What is so sad is analysts were calling for ridiculously high numbers on Seroquel XR. I said they were way too high. I said $3M per quarter. Now it looks like my estimate was way too high as well...